TVGN

Conviction 33HealthcareScan · Mon, Aug 10, 2026

Hanging man

TVGN$6.41-0.93%

ResistanceSupportVol 14

Vol MA14 14.41K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Tevogen Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.tevogen.com ↗

Price6.41

Change-0.93%

Gap+0.00%

Rel volume1.09×

Avg volume14.87K

Avg $ vol82.42K

SMA 205.53

SMA 507.19

SMA 2003.94

Price vs 50-10.80%

Price vs 200+62.83%

MA stackmixed

50/200 cross—

Supertrendup · 4.67

RSI (14)52

MACD hist0.24

MACD cross—

Stoch %K / %D72 / 74

ADX (14)24

+DI / −DI22 / 21

RSI divergence—

MACD divergenceBullish

ATR %+11.31%

ADR %11.00%

52w high11.67

52w low0.1551

From 52w high-45.07%

Above 52w low+4032.82%

New 52w highNo

SqueezeOff

Bollinger width81.27%

%B0.70

Donchian pos73.31%

Donchian high7.42

Donchian low3.64

AVWAP (52w high)6.69

vs AVWAP high-4.24%

AVWAP (52w low)4.28

vs AVWAP low+49.87%

OBV trendFlat

Chaikin MF (20)0.33

Today vs 20d1.09×

Avg vol (14d)14.41K

Avg vol (20d)14.87K

Avg $ vol (20d)82.42K

Market cap26.84M

RS 3m (vs SPY)-19.20%

RS 6m (vs SPY)+2195.78%

RS line new highNo

Trend template5/8

Technical rank77.6

1 week-8.69%

1 month+26.68%

3 months-14.30%

6 months+2234.30%

1 year+637.54%

YTD+1661.96%

P/E-1.02

P/B-2.73

P/S—

P/FCF-2.17

EPS-8.08

Div yield—

ROE266.97%

ROA—

Debt/Eq0.00

Current0.29

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-91.41%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value26.84M

Revenue—

Net income-5.45M

Gross profit—

Free cash flow-12.39M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out4.19M

Employees18

ListedThu, Feb 15, 2024

Free float44.94M

Float %22.6%

Short interest64.85K

Days to cover3.9d

Short volume40.1%

Squeeze score21 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction33 / 100

Pattern quality—

Tech rank77.6 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHanging man

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TVGN

All disclosures →

No recent disclosed trades by Congress in TVGN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TVGN · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Desai Kirti Chief Financial Officer · Common Stock · 2026-07-10	Grant	40K	—	2026-07-10	2026-07-10
Feike Jeffrey L. Director · Common Stock · 2026-07-10	Grant	40K	—	2026-07-10	2026-07-10
Goh Keow Lin Director · Common Stock · 2026-07-10	Grant	40K	—	2026-07-10	2026-07-10
PODLOGAR SUSAN M Director · Common Stock · 2026-07-10	Grant	40K	—	2026-07-10	2026-07-10
Patton Curtis L. Director · Common Stock · 2026-07-10	Grant	40K	—	2026-07-10	2026-07-10
Saadi Ryan H. Chief Executive Officer · Common Stock · 2026-07-10	Grant	1.22M	—	2026-07-10	2026-07-10
Sordillo Victor J. Director · Common Stock · 2026-07-10	Grant	40K	—	2026-07-10	2026-07-10

SEC filings

EDGAR filings in TVGN · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.